(-)-beta-Chamigrene

Details

Top
Internal ID a06e4ea9-c388-46b3-9506-b96a39a80d99
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Chamigranes
IUPAC Name (6R)-5,5,9-trimethyl-1-methylidenespiro[5.5]undec-9-ene
SMILES (Canonical) CC1=CCC2(CC1)C(=C)CCCC2(C)C
SMILES (Isomeric) CC1=CC[C@@]2(CC1)C(=C)CCCC2(C)C
InChI InChI=1S/C15H24/c1-12-7-10-15(11-8-12)13(2)6-5-9-14(15,3)4/h7H,2,5-6,8-11H2,1,3-4H3/t15-/m1/s1
InChI Key WLNGPDPILFYWKF-OAHLLOKOSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 4.70
Atomic LogP (AlogP) 4.87
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
beta-Chamigrene
18431-82-8
Chamigrene
Chamigren
(-)-chamigrene
(R)-beta-chamigrene
(6R)-3,7,7-trimethyl-11-methylidenespiro[5.5]undec-2-ene
(6R)-5,5,9-trimethyl-1-methylidenespiro[5.5]undec-9-ene
CHEBI:10359
DTXSID60939822
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of (-)-beta-Chamigrene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9893 98.93%
Caco-2 + 0.9563 95.63%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability + 0.7286 72.86%
Subcellular localzation Lysosomes 0.6687 66.87%
OATP2B1 inhibitior - 0.8517 85.17%
OATP1B1 inhibitior + 0.9055 90.55%
OATP1B3 inhibitior + 0.8000 80.00%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior - 0.6693 66.93%
P-glycoprotein inhibitior - 0.9604 96.04%
P-glycoprotein substrate - 0.9242 92.42%
CYP3A4 substrate - 0.5000 50.00%
CYP2C9 substrate - 0.8046 80.46%
CYP2D6 substrate - 0.7790 77.90%
CYP3A4 inhibition - 0.8536 85.36%
CYP2C9 inhibition - 0.7264 72.64%
CYP2C19 inhibition - 0.6231 62.31%
CYP2D6 inhibition - 0.9353 93.53%
CYP1A2 inhibition - 0.8616 86.16%
CYP2C8 inhibition - 0.8776 87.76%
CYP inhibitory promiscuity - 0.7107 71.07%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7300 73.00%
Carcinogenicity (trinary) Warning 0.4606 46.06%
Eye corrosion - 0.8710 87.10%
Eye irritation + 0.9085 90.85%
Skin irritation - 0.5584 55.84%
Skin corrosion - 0.9769 97.69%
Ames mutagenesis - 0.8464 84.64%
Human Ether-a-go-go-Related Gene inhibition - 0.5000 50.00%
Micronuclear - 0.9800 98.00%
Hepatotoxicity + 0.6451 64.51%
skin sensitisation + 0.8441 84.41%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity - 0.6000 60.00%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity - 0.7337 73.37%
Acute Oral Toxicity (c) III 0.8649 86.49%
Estrogen receptor binding - 0.9471 94.71%
Androgen receptor binding - 0.5601 56.01%
Thyroid receptor binding - 0.7794 77.94%
Glucocorticoid receptor binding - 0.7533 75.33%
Aromatase binding - 0.7219 72.19%
PPAR gamma - 0.8358 83.58%
Honey bee toxicity - 0.8367 83.67%
Biodegradation + 0.5750 57.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.66% 97.25%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 90.72% 86.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.56% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.26% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.85% 96.09%
CHEMBL1937 Q92769 Histone deacetylase 2 84.09% 94.75%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.63% 100.00%
CHEMBL5805 Q9NR97 Toll-like receptor 8 81.55% 96.25%
CHEMBL2581 P07339 Cathepsin D 81.49% 98.95%
CHEMBL4208 P20618 Proteasome component C5 80.23% 90.00%
CHEMBL2996 Q05655 Protein kinase C delta 80.12% 97.79%

Cross-Links

Top
PubChem 442353
NPASS NPC154816
LOTUS LTS0274399
wikiData Q27108622